• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [21959 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2004     NIHR Horizon Scanning Centre (NIHR HSC) Cinacalcet HCl for secondary hyperparathyroidism - horizon scanning review
2013     NIHR Horizon Scanning Centre (NIHR HSC) Erlotinib (Tarceva) for the adjuvant treatment of EGFR positive non-small cell lung cancer
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ticagrelor (Brilique) for secondary prevention of cardiovascular disease events in patients with prior myocardial infarction
2015     NIHR Horizon Scanning Centre (NIHR HSC) Ipilimumab (Yervoy) for chemotherapy-naïve hormone-relapsed metastatic prostate cancer
2015     NIHR Horizon Scanning Centre (NIHR HSC) Pembrolizumab (Keytruda) for advanced or metastatic urothelial cancer – second line
2002     NIHR Horizon Scanning Centre (NIHR HSC) Transpupillary thermotherapy for age-related macular degeneration - horizon scanning review
2004     NIHR Horizon Scanning Centre (NIHR HSC) Roflumilast for asthma and chronic obstructive pulmonary disease - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Dabigatran etexilate for primary deep vein thrombosis prevention post hip and knee surgery: horizon scanning technology briefing
2013     NIHR Horizon Scanning Centre (NIHR HSC) LCQ908 (Pradigastat) for familial chylomicronaemia syndrome – first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Padeliporfin (Tookad soluble) for localised prostate cancer – first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Plitidepsin (Aplidin) for relapsed and refractory multiple myeloma – fourth line
2002     NIHR Horizon Scanning Centre (NIHR HSC) Tirapazamine for non-small cell lung cancer - horizon scanning review
2004     NIHR Horizon Scanning Centre (NIHR HSC) Infliximab for psoriasis - horizon scanning review
2013     NIHR Horizon Scanning Centre (NIHR HSC) Gevokizumab for chronic non-infectious uveitis
2013     NIHR Horizon Scanning Centre (NIHR HSC) Alicaforsen for pouchitis – second line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Pegaspargase (Oncaspar) for acute lymphoblastic leukaemia
2015     NIHR Horizon Scanning Centre (NIHR HSC) Regorafenib (Stivarga) for hepatocellular carcinoma – second line
2002     NIHR Horizon Scanning Centre (NIHR HSC) Tissue engineered heart valves - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (avastin) for advanced and metastatic breast cancer (stages III and IV): horizon scanning review
2013     NIHR Horizon Scanning Centre (NIHR HSC) ABT-450/ritonavir/ABT-267 in combination with ABT-333 for chronic genotype-1 hepatitis C infection
2013     NIHR Horizon Scanning Centre (NIHR HSC) Trastuzumab emtansine (Kadcyla) for patients with HER2 positive locally advanced or metastatic relapsed gastric cancers
2015     NIHR Horizon Scanning Centre (NIHR HSC) Rindopepimut for EGFRvIII positive glioblastoma multiforme - first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Ribociclib for advanced hormone receptor positive, HER2 negative breast cancer – first line
2003     NIHR Horizon Scanning Centre (NIHR HSC) AC2993 for type 2 diabetes - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (avastin) for advanced renal cell carcinoma: horizon scanning review
2013     NIHR Horizon Scanning Centre (NIHR HSC) Sofosbuvir with ledipasvir for hepatitis C, genotype 1
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ramucirumab for hepatocellular cancer – second line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Rociletinib for advanced or recurrent non-small cell lung cancer with the EGFR T790M mutation
2015     NIHR Horizon Scanning Centre (NIHR HSC) Selumetinib for KRAS mutation-positive advanced non-small cell lung cancer – second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) AXS 02 (zoledronic acid) for type I complex regional pain syndrome
2003     NIHR Horizon Scanning Centre (NIHR HSC) Agomelatine for depression - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Oncophage for renal cell carcinoma - horizon scanning review
2013     NIHR Horizon Scanning Centre (NIHR HSC) Leuco-methylthioninium for alzheimer's disease
2013     NIHR Horizon Scanning Centre (NIHR HSC) Pixantrone (Pixuvri) in combination with rituximab for diffuse large B-cell lymphoma or grade 3 follicular lymphoma – second and subsequent line
2014     NIHR Horizon Scanning Centre (NIHR HSC) Idelalisib (Zydelig) for relapsed chronic lymphocytic leukaemia – in combination with bendamustine and rituximab
2015     NIHR Horizon Scanning Centre (NIHR HSC) Talazoparib for locally advanced and/or metastatic breast cancer with germline BRCA 1/2 positive mutation
2016     NIHR Horizon Scanning Centre (NIHR HSC) Blinatumomab (Blincyto) for B-precursor acute lymphoblastic leukaemia minimal residual disease – patients in remission
2003     NIHR Horizon Scanning Centre (NIHR HSC) Alvimopan for post-operative ileus - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib tosylate (nexavar) for advanced renal cell carcinoma: horizon scanning review
2013     NIHR Horizon Scanning Centre (NIHR HSC) Miniprobes™ for probe-based confocal laser endomicroscopy in bladder, pancreatic or bile duct cancer
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab (Arzerra) for relapsed chronic lymphocytic leukaemia
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ipilimumab (Yervoy) for metastatic hormone-relapsed prostate cancer following docetaxel treatment and radiotherapy
2015     NIHR Horizon Scanning Centre (NIHR HSC) Venetoclax for chronic lymphocytic leukaemia with 17p deletion or TP53 mutation
2016     NIHR Horizon Scanning Centre (NIHR HSC) Duvelisib for relapsed chronic lymphocytic leukaemia – second and subsequent line
2003     NIHR Horizon Scanning Centre (NIHR HSC) BEC-2 for small cell lung cancer - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib for advanced hepatocellular carcinoma (HCC): horizon scanning review
2013     NIHR Horizon Scanning Centre (NIHR HSC) Glysure intravascular continuous glucose monitoring system for glycaemic control in intensive care
2013     NIHR Horizon Scanning Centre (NIHR HSC) IceSense3™ Cryoablation System for breast fibroadenoma
2013     NIHR Horizon Scanning Centre (NIHR HSC) MEK162 for NRAS mutation positive advanced malignant melanoma – first and second line
2014     NIHR Horizon Scanning Centre (NIHR HSC) Lanreotide for unresectable, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumours – first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Vincristine liposomal (Marqibo) for relapsed or refractory acute lymphoblastic leukaemia – third line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Duvelisib for relapsed follicular lymphoma - third and subsequent line
2003     NIHR Horizon Scanning Centre (NIHR HSC) Bortezomib for multiple myeloma - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Remote monitoring of implantable cardiac devices for cardiac arrhythmia - horizon scanning review
2010     NIHR Horizon Scanning Centre (NIHR HSC) Afatinib for advanced and/or metastatic non-small cell lung cancer (NSCLC) with EGFR mutation - first line
2013     NIHR Horizon Scanning Centre (NIHR HSC) Afatinib for locally advanced, recurrent or metastatic head and neck squamous cell carcinoma – second line
2013     NIHR Horizon Scanning Centre (NIHR HSC) EndoVE® for colorectal cancer
2013     NIHR Horizon Scanning Centre (NIHR HSC) MK-3475 for advanced melanoma – first or second line, in patients naïve to ipilimumab
2014     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab for advanced melanoma – second or third line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Vincristine liposomal (Marqibo) in combination with chemotherapy for elderly patients with newly diagnosed CD20 positive diffuse large B-cell lymphoma – first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Lenvatinib (Lenvima) for unresectable hepatocellular carcinoma – first line
2003     NIHR Horizon Scanning Centre (NIHR HSC) CPH82 for rheumatoid arthritis - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Implantable miniature telescopes for advanced, untreatable age-related macular degeneration: horizon scanning review
2010     NIHR Horizon Scanning Centre (NIHR HSC) AIN-457 for posterior uveitis
2013     NIHR Horizon Scanning Centre (NIHR HSC) Astuprotimut-r (Zumagev) for stage III, MAGE-A3 positive malignant melanoma – adjuvant therapy
2013     NIHR Horizon Scanning Centre (NIHR HSC) Curodont™ Repair and Curodont Protect™ for the treatment and prevention of tooth decay
2013     NIHR Horizon Scanning Centre (NIHR HSC) MK-3475 for advanced or recurrent PD-L1 positive non-small cell lung cancer – second line
2014     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab for BRAF V600 mutation– negative advanced melanoma – first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Eprodisate disodium (Kiacta) for AA amyloidosis
2016     NIHR Horizon Scanning Centre (NIHR HSC) Masitinib for relapsed or refractory peripheral T-cell lymphoma
2003     NIHR Horizon Scanning Centre (NIHR HSC) Drugs for irritable bowel syndrome - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Grazax allergy vaccine for moderate to severe seasonal allergic rhinitis (grass pollen hay fever): horizon scanning review
2010     NIHR Horizon Scanning Centre (NIHR HSC) Apixaban for stroke prevention in atrial fibrillation
2013     NIHR Horizon Scanning Centre (NIHR HSC) Lapatinib (Tyverb) for HER2-positive breast cancer – adjuvant therapy in combination with or following trastuzumab
2013     NIHR Horizon Scanning Centre (NIHR HSC) ARGOS-IO for the measurement of intraocular pressure in glaucoma
2013     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for newly diagnosed glioblastoma multiforme – first line
2014     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab for BRAF V600 mutation-positive advanced melanoma – first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) STG 320 for allergic rhinitis
2003     NIHR Horizon Scanning Centre (NIHR HSC) Duloxetine for female stress urinary incontinence - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Taribavirin hydrochloride for chronic hepatitis C virus: horizon scanning review
2010     NIHR Horizon Scanning Centre (NIHR HSC) Axitinib for advanced and/or metastatic renal cell carcinoma - second line
2013     NIHR Horizon Scanning Centre (NIHR HSC) Trebananib in combination with chemotherapy for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer
2013     NIHR Horizon Scanning Centre (NIHR HSC) LDK378 for ALK-activated advanced non-small cell lung cancer – second and subsequent lines
2013     NIHR Horizon Scanning Centre (NIHR HSC) EndoStim LES Stimulation System for severe gastro-oesophageal reflux
2013     NIHR Horizon Scanning Centre (NIHR HSC) Asfotase alfa for hypophosphatasia
2014     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab with ipilimumab for advanced melanoma – first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Cerliponase alfa for neuronal ceroid lipofuscinosis type 2 (CLN2 disease)
2003     NIHR Horizon Scanning Centre (NIHR HSC) Erlotinib for pancreatic and non-small cell lung cancer - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Telbivudine for chronic hepatitis B: horizon scanning review
2010     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) in combination with trastuzumab and docetaxel for metastatic HER2 positive breast cancer - first line
2013     NIHR Horizon Scanning Centre (NIHR HSC) Tertomotide for locally advanced or metastatic pancreatic cancer
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab (Arzerra) for relapsed diffuse large B-cell lymphoma
2013     NIHR Horizon Scanning Centre (NIHR HSC) IUB™ SCu300A intrauterine device for contraception
2013     NIHR Horizon Scanning Centre (NIHR HSC) Methyl aminolevulinate (Visonac) photodynamic therapy for acne vulgaris
2014     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab for advanced or metastatic clear-cell renal cell carcinoma – second or third line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Pridopidine (Huntexil) for Huntington's disease
2003     NIHR Horizon Scanning Centre (NIHR HSC) Etanercept for ankylosing spondylitis - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Tolevamer for clostridium difficile associated diarrhea: horizon scanning review
2010     NIHR Horizon Scanning Centre (NIHR HSC) Erlotinib hydrochloride (Tarceva) for advanced non-small cell lung cancer with activating EGFR mutations - first line
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ospemifene for vulvo-vaginal atrophy in postmenopausal women